Glimpse Group, Inc. (VRAR) Insider Ownership

Historic Insider Ownership Trends

As of March 23, 2026, the three largest insider holders of VRAR are Maydan Rothblum (Cfo And Coo, 486.45K shares), Jeffrey D. Enslin (Director, 243.63K shares), Lemuel Amen (Director, 148.12K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Maydan Rothblum Cfo And Coo 486,450 0 31 May, 2023
Jeffrey D. Enslin - 0 243,631 04 Mar, 2024
Lemuel Amen - 148,122 0 04 Mar, 2024
Jeffrey Ralph Meisner Chief Revenue Officer 84,016 0 12 Jan, 2023
Lyron L Bentovim President And Ceo 65,778 0 19 Dec, 2025
Jeffrey D. Enslin - 3,000 0 17 Mar, 2022
David John Smith Chief Creative Officer 250 0 04 Oct, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
18 Dec, 2025 Lyron L Bentovim Common Stock A 3,172 $0.98 65,778 D A
11 Dec, 2024 Lyron L Bentovim Common Stock A 10,634 $1.15 62,606 D A
29 Apr, 2024 Tamar Elkeles Stock Option (Right to Purchase) A 20,000 $0.00 20,000 D A
24 May, 2024 Lyron L Bentovim Common Stock A 1,780 $1.07 44,873 D A
23 May, 2024 Lyron L Bentovim Common Stock A 1,214 $1.07 43,093 D A
22 May, 2024 Lyron L Bentovim Common Stock A 2,755 $1.07 41,879 D A
21 May, 2024 Lyron L Bentovim Common Stock A 1,900 $1.03 39,124 D A
29 Feb, 2024 David John Smith Stock Option (Right to Purchase) D 64,349 $0.00 0 D D
29 Feb, 2024 Tyler Gates Stock Option (Right to Purchase) D 9,216 $0.00 0 D D
29 Feb, 2024 Maydan Rothblum Stock Option (Right to Purchase) D 320,180 $0.00 0 D D
29 Feb, 2024 Lyron L Bentovim Stock Option (Right to Purchase) D 90,188 $0.00 0 D D
01 Mar, 2024 David John Smith Stock Option (Right to Purchase) A 51,480 $0.00 51,480 D A
01 Mar, 2024 Maydan Rothblum Stock Option (Right to Purchase) A 306,145 $0.00 306,145 D A
01 Mar, 2024 Tyler Gates Stock Option (Right to Purchase) A 5,532 $0.00 5,532 D A
01 Mar, 2024 Lyron L Bentovim Stock Option (Right to Purchase) A 72,153 $0.00 1,282,153 D A
29 Feb, 2024 Ian Morgan Charles Stock Option (Right to Purchase) D 30,560 $0.00 0 D D
01 Mar, 2024 Lemuel Amen Common Stock A 23,122 $0.00 148,122 D A
01 Mar, 2024 Jeffrey D. Enslin Common Stock A 215,631 $0.00 243,631 I A
01 Mar, 2024 Ian Morgan Charles Stock Option (Right to Purchase) A 20,475 $0.00 44,475 D A
01 Mar, 2024 Jeffrey D. Enslin Common Stock A 25,000 $0.00 243,631 I A